Last update Feb. 26, 2018
Topically used to treat cutaneous, eye and ear infections.
The small dose used and poor plasma uptake of most topical ophthalmic and dermal preparations make it very unlikely that a significant amount would pass into breast milk.
Plasma levels after topical application on skin are 1000 times lower than those observed after systemic administration (Fluhr 1998).
Possible absorption following ophthalmologic administration could be minimized by following appropriate ophthalmologist instructions (eg finger-compression on the tear sac at the internal eye’s corner for one minute after application of drops)
Even after been taken systemically (orally or parenterally), the excretion into breastmilk is poor, which would impede the development of neonatal gray syndrome.
Do not apply on the chest to prevent the infant from ingesting it. Otherwise, apply it after a breast feeding and clean it up thoroughly with water before the next feeding.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM